Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.20B.
ENTERPRISE VALUE (EV)
$4.20B
AbCellera Biologics Inc.
Market Cap
$4.33B
Enterprise Value (EV)
$4.20B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $4.33B | $4.20B |
| LivaNova PLC (LIVN)vs › | $4.21B | $4.05B |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | $4.29B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.47B | $4.75B |
| ICU Medical, Inc. (ICUI)vs › | $4.06B | $5.03B |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.61B | $4.60B |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.77B | $4.15B |
| LifeStance Health Group, Inc. (LFST)vs › | $4.78B | $4.75B |
| CareDx, Inc (CDNA)vs › | $3.69B | $3.34B |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.89B | $5.13B |
Market Cap
$4.33B
Total Debt
$0.00
Cash
$128.51M
Enterprise Value
$4.20B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
